Skip to main content

Table 3 RAND SF-36 at baseline, six months, and baseline-six months

From: Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus

  Placebo (N=14) Fish oil (N=18} Mann–Witney U
  Median [IQR] Median [IQR] p-value
Baseline    
 Physical functioning 75.00 [52.90–90.00] 32.5 [17.50–55.00] .004
 Role functioning/physical 75.00 [0.00–100.00] 0.00 [0.00–25.00] .022
 Role functioning/emotional 66.67 [0.00–100.00] 0.00 [0.00–16.67] .021
 Energy/fatigue 55.00 [28.75–76.25] 20.00 [10.00–46.25] .016
 Emotional well-being 68.00 [60.00–89.00] 40.00 [28.00–64.00] .006
 Social functioning 68.75 [46.88–90.63] 37.50 [21.88–62.50] .006
 Pain 62.50 [45.00–92.50] 22.50 [9.38–47.50] .001
 General health 42.50 [28.75–62.50] 30 [18.75–50.00] .100
Six Months    
 Physical functioning 77.50 [48.75–96.25] 30.00 [15.00–51.25] .005
 Role functioning/ physical 75.00 [43.75–100.00] 0.00 [0.00–75.00] .015
 Role functioning/ emotional 100.00 [50.00–100.00] 16.67 [0.00–100.00] .217
 Energy/fatigue 55.00 [32.50–70.00] 37.50 [20.00–56.25] .138
 Emotional well-being 78.00 [61.00–88.00] 66.00 [44.00–77.00] .037
 Social functioning 68.75 [50.00–100.00] 50.00 [25.00–75.00] .023
 Pain 72.50 [46.25–92.50] 32.5 [22.50–57.50] .009
 General health 52.50 [20.00–60.00] 37.50 [30.00–51.25] .380
Six Months-Baseline    
 Physical functioning 5.00 [-10.00–21.25] -2.50 [-10.00–16.25] .468
 Role functioning/physical 0.00 [0.00–25.00] 0.00 [0.00–25.00] .878
 Role functioning/emotional 0.00 [0.00–33.33] 0.00 [0.00–50.00] .693
 Energy/fatigue -2.50 [-6.25–11.25] 10.00 [-1.25–21.25] .092
 Emotional well-being 4.00 [-5.00–14.00] 16.00 [-1.00–33.00] .070
 Social functioning 6.25 [-9.38–18.75] 6.25 [-12.50–37.50] .657
 Pain -11.25 [-14.38–18.13] 10.00 [0.00–25.00] .105
 General health -2.50 [-10.00–6.25] 5.00 [-11.25–23.75] .312
  1. RAND SF-36 data are presented as median and interquartile range (IQR) for all completer patients at baseline, study completion, and difference between baseline and six months